Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Cov2, Immune Response”

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT04818736
What this trial is testing

COVID-19 Vaccine For Indirect Protection

Who this might be right for
Vaccine Preventable Disease
McMaster University
Not applicableEnded earlyNCT04894253
What this trial is testing

Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus

Who this might be right for
Systemic Lupus
University Hospital, Strasbourg, France 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07597070
What this trial is testing

Universal Immunization to Fortify Immunotherapy Efficacy and Response

Who this might be right for
Stage 4 NSCLC
University of Florida 500
Not applicableUnknownNCT03944603
What this trial is testing

Longitudinal Innate Immunity and Aging Study

Who this might be right for
Healthy Older Adults Ages 60-89
University of Colorado, Denver 300
Not applicableActive Not RecruitingNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Not applicableStudy completedNCT04510012
What this trial is testing

Characterizing the Immune Response and Neuronal Damage in COVID-19

Who this might be right for
SARS-CoV InfectionCovid-19
Insel Gruppe AG, University Hospital Bern 88
Not applicableWithdrawnNCT05672654
What this trial is testing

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

Who this might be right for
HIV SeropositivityImmunodeficiencyVaccination Reaction+1 more
University Hospital, Ghent
Not applicableStudy completedNCT05951920
What this trial is testing

Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 12
Post-approval studies (Phase 4)Study completedNCT05778383
What this trial is testing

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes

Who this might be right for
Zinc DeficiencySars-CoV-2 Infection
Parc de Salut Mar 75
Not applicableStudy completedNCT04562285
What this trial is testing

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Who this might be right for
Covid19
Henry Ford Health System 829
Not applicableLooking for participantsNCT05458440
What this trial is testing

Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity

Who this might be right for
COVID-19
Central Hospital, Nancy, France 32
Not applicableLooking for participantsNCT05858502
What this trial is testing

Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants

Who this might be right for
COVID-19
Institut Pasteur 90
Testing effectiveness (Phase 2)UnknownNCT04748471
What this trial is testing

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

Who this might be right for
Prevention of COVID19
Assistance Publique - Hôpitaux de Paris 180
Large-scale testing (Phase 3)UnknownNCT05059106
What this trial is testing

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

Who this might be right for
SARS-CoV-2
Federal University of Espirito Santo 29,637
Not applicableStudy completedNCT04843774
What this trial is testing

Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

Who this might be right for
Multiple Sclerosis
NYU Langone Health 64
Not applicableEnded earlyNCT05124574
What this trial is testing

Transplacental Transmission of COVID-19

Who this might be right for
SARS-COV-2 Infection
Centre Hospitalier Universitaire de Saint Etienne 10
Early research (Phase 1)Looking for participantsNCT07464314
What this trial is testing

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Who this might be right for
Influenza, Human+COVID-19
GlaxoSmithKline 225
Not applicableStudy completedNCT04424004
What this trial is testing

MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study

Who this might be right for
COVID 19
Duke University 300
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Not applicableStudy completedNCT04431414
What this trial is testing

Immune Responses to the Virus That Causes COVID-19

Who this might be right for
SARS-CoV-2COVID-19
COVID-19 Prevention Network 953
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation